Completed PHASE4 INTERVENTIONAL 1-arm NCT02036073

Effect of Erythropoietin on Preterm Brain Injury (EPO)

Sponsor: Zhengzhou Children's Hospital, China

Interventions recombinant human erythropoietin

Updated 5 times since 2017 Last updated: Jan 13, 2014 Started: Jan 31, 2009 Primary completion: Jun 30, 2012 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Premature Birth and is currently completed. Zhengzhou Children's Hospital, China leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zhengzhou Children's Hospital, China
Zhengzhou University

Data source: Zhengzhou Children's Hospital, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zhengzhou, China